Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT04240613 Completed - Clinical trials for Urinary Incontinence, Urge

Tension-free Vaginal Tape Obturator for the Treatment of Urinary Incontinence -Long-term Follow-up

Start date: January 2004
Phase: N/A
Study type: Interventional

The efficacy of TVT-O (tension-free vaginal tape obturator) is well established in patients with stress urinary incontinence (SUI). The objective of this study was to evaluate the efficacy, safety and patient satisfaction of TVT-O in patients suffering from primary, mixed (MUI) or recurrent urinary incontinence (UI) in long-term follow-up.

NCT ID: NCT04237753 Active, not recruiting - Clinical trials for Urinary Incontinence

Remote Access to Urinary Incontinence Treatment for Women Veterans

PRACTICAL
Start date: April 6, 2020
Phase: N/A
Study type: Interventional

This study is about assessing the helpfulness of two treatment delivery methods for bladder leakage or urinary incontinence. It is being funded by the Department of Veterans Affairs. By doing this study, the investigators hope to learn which treatment method is the most helpful remote delivery method for treating bladder leakage. The total participation time in this research is 6 months. During the first 8 -12 weeks of the study, you will receive standard of care from an online educational program (MyHealtheBladder) or a video visit with a provider through VA Video Connect. You will be selected by chance to receive MyHealtheBladder or VA Video Connect. About half-way through the study, the investigators will ask you about your bladder symptoms. If your bladder symptoms are not better, you will be selected by chance to continue the previous treatment or receive an initial or booster video session with a provider. Throughout the study, you will be asked to answer questions related to your health, bladder leakage, costs due to bladder leakage, and track your behavioral training.

NCT ID: NCT04233645 Completed - Clinical trials for Urinary Incontinence

Voiding Diary Video

Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate patient adherence and completeness of intake and voiding diaries. The secondary goal is to compare the satisfaction and understanding of patients of the intake and voiding trial diaries directions.

NCT ID: NCT04227184 Recruiting - Clinical trials for Urgency Urinary Incontinence

Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence

Start date: February 13, 2020
Phase: Phase 4
Study type: Interventional

This is a randomized double-blind crossover trial of trospium and placebo in women with urgency urinary incontinence, with evaluation (history, physical, incontinence evaluation and brain MRI) at baseline, and after each course of therapy. The investigators will evaluate functional brain changes in relation to bladder improvement in order to improve our knowledge of the brain's role in the continence mechanism.

NCT ID: NCT04213339 Completed - Clinical trials for Urinary Incontinence in Geriatric Population

Effectiveness of Kegal Exercises on Urinary Incontinence Impact in Geriatric Incontinence

Start date: January 3, 2020
Phase: N/A
Study type: Interventional

This research study was used to determine effectiveness of kegal exercise on urinary incontinence impact in geriatric incontinence. There were two groups, One group was experimental which was subjected to Kegel exercises while other was control group without any treatment.

NCT ID: NCT04211831 Completed - Clinical trials for Overactive Bladder With Urge Urinary Incontinence

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Start date: December 16, 2019
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, and tolerability of a single dose of URO-902 24 milligrams (mg) and 48 mg (administered via intradetrusor injection), compared with placebo, in participants with overactive bladder (OAB) and urge urinary incontinence (UUI) up to 48 weeks post-dose.

NCT ID: NCT04211285 Completed - Depression Clinical Trials

e-GAB: Electronic Geriatric Assessment Bundle: Development of an Arabic Self-administered Android CGA Application

Start date: August 1, 2018
Phase:
Study type: Observational

The aim of this study is to design and assess the accuracy of administering the electronic Geriatric Assessment Bundle (e-GAB) compared to geriatrician performed comprehensive geriatric assessment (CGA) in a group of Egyptian elderly. The development of an Arabic software platform for CGA can improve the clinical practice by providing a valid user friendly tool to collect and analyze data for geriatric patients attending non- Geriatric health care service.

NCT ID: NCT04206085 Completed - Clinical trials for Stress Urinary Incontinence

Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This is a prospective, randomized, single-blind, study comparing both the Viveve Treatment (RF plus cryogen) and cryogen alone treatment versus sham treatment in patients with mild to moderate stress urinary incontinence.

NCT ID: NCT04193176 Completed - Chronic Cough Clinical Trials

Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)

Start date: May 10, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of gefapixant, in improving symptoms of cough-induced stress urinary incontinence (SUI) in adult female participants with refractory or unexplained chronic cough. The primary hypothesis is that gefapixant is superior to placebo in reducing the frequency of cough-induced SUI episodes over 12 weeks.

NCT ID: NCT04191863 Completed - Epilepsy Clinical Trials

Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.

Start date: September 1, 2018
Phase:
Study type: Observational

Our study, retrospectively evaluate the characteristics of and the risk factors for the occurrence of nocturnal enuresis in epileptic children kept on valproate monotherapy. Epileptic children with the age ranged 5 up to 15 years who were started and kept up on valproate monotherapy. In this study, a child determined to have nocturnal enuresis based on the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fourth edition: "an involuntary voiding of urine during sleep, with a severity of at least twice a week, in children aged 5 years or older, in the absence of congenital or acquired defects of the nervous system."